Novartis AG (XSWX:NOVN) Other Operating Expense: CHF359 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:NOVN Novartis AG XSWX:NOVN
80 GF Score
Price CHF125.34
GF Value CHF104.09
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Novartis AG Other Operating Expense?

Novartis AG XSWX:NOVN -0.16% 80 Other Operating Expense is CHF359 Mil as of Jun. 2026. GuruFocus rates XSWX:NOVN with a GF Score™ of 80/100 and a GF Value™ of CHF104.09 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Novartis AG's Other Operating Expense for the three months ended in Jun. 2026 was CHF322 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was CHF359 Mil.

Novartis AG's quarterly Other Operating Expense declined from Dec. 2025 (CHF24 Mil) to Mar. 2026 (CHF-39 Mil) but then increased from Mar. 2026 (CHF-39 Mil) to Jun. 2026 (CHF322 Mil).

Novartis AG's annual Other Operating Expense increased from Dec. 2023 (CHF459 Mil) to Dec. 2024 (CHF1,572 Mil) but then declined from Dec. 2024 (CHF1,572 Mil) to Dec. 2025 (CHF704 Mil).

Novartis AG Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Novartis AG's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG Other Operating Expense Chart

Novartis AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 658.51 2,392.35 459.21 1,571.89 703.66

Novartis AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 391.15 52.54 23.91 -39.36 322.12
XSWX:NOVN
80GF Score
Novartis AG XSWX:NOVN
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novartis AG Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF359 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of CHF359 Mil mean?
Novartis AG (XSWX:NOVN) has a Other Operating Expense of CHF359 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Novartis AG and its competitors.
Is Novartis AG's Other Operating Expense too high?
Novartis AG's current Other Operating Expense is CHF359 Mil. Overall, Novartis AG has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Novartis AG's Other Operating Expense compare to LLY and JNJ?
Novartis AG's Other Operating Expense of CHF359 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Novartis AG and its competitors. Novartis AG's current Other Operating Expense is CHF359 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis AG stock overvalued right now?
Based on GuruFocus' analysis, Novartis AG (XSWX:NOVN) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF104.09, compared to a current price of CHF125.34 — trading 20.4% above its estimated fair value. The current Other Operating Expense is CHF359 Mil. Novartis AG's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Novartis AG (XSWX:NOVN), the current Other Operating Expense is CHF359 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novartis AG (XSWX:NOVN) Overvalued in 2026?

Based on GuruFocus' analysis, Novartis AG stock appears to be overvalued. The current stock price of CHF125.34 is trading 20.4% above its estimated GF Value™ of CHF104.09. GuruFocus considers Novartis AG to be Modestly Overvalued.

Key valuation signals for XSWX:NOVN:

  • Other Operating Expense: CHF359 Mil
  • GF Value™: CHF104.09 vs. price of CHF125.34 (20.4% above fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the XSWX:NOVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novartis AG Business Description

Address Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
80GF Score

Get the complete analysis for XSWX:NOVN

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF125.34
Price
CHF104.09
GF Value